Tumblr Yahoos: Old ...
Health Care: Drugs
Spectrum Pharmaceuticals Inc (SPPI: NASDAQ)
$8.04 -0.10 | -1.29%
05/20/13 - 02:41 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 8.14 |
| 52 Week High | 17.48 |
| 52 Week Low | 6.92 |
| Avg. Daily Vol. (Mil) | 1.47 |
| Beta (3 year) | 1.90 |
| Share Related Items | |
| Mkt Cap (Mil) | 488.62 |
| Shares Out (Mil) | 60.03 |
| Float (Mil) | 49.58 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 21.00 |
| Financial Strength | |
| Quick Ratio | 2.10 |
| Current Ratio | 2.30 |
| LT Debt/ Equity | 0.29 |
| Total Debt / Equity | 0.29 |
| Valuation Ratios | |
| Price Earnings | 11.50 |
| Price/Sales | 1.98 |
| Price/Book | 1.72 |
| Price/Cash Flow | 12.70 |
| Per Share Data | |
| Earnings | 0.71 |
| Sales | 4.11 |
| Book Value | 4.74 |
| Cash Flow | 0.64 |
| Business Summary | |
|---|---|
| Spectrum Pharmaceuticals Inc is a commercial stage biotechnology company integrated in commercial and drug development operations and primarily in oncology and hematology. | |
| General Information | |
| 11500 South Eastern Avenue
Suite 240 Henderson, NV 89052 |
|
| www.sppirx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 193 | |
| CEO: Dr. Rajesh C. Shrotriya, | |
| Short Interest | |
| Current Month (Mil) | 21.56 |
| Previous Month (Mil) | 22.17 |
| Short Interest Ratio (Days) | 24.30 |
| Management Effectiveness | |
| Return on Equity | 15.90 |
| Return on Assets | 9.30 |
| Return on Investments | 12.40 |
| Profitability | |
| Gross Margin | 75.80 |
| EBIT Margin | 20.10 |
| Profit Margin | 18.30 |
Portfolios with SPPI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- UserStock/ETF
- ContributorHeavily Shorted Market Lead...
- ContributorHot Biotech Trades for Seco...
Latest SPPI Headlines from TheStreet
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Dumbest Things 'April Fools' Quiz 03.29.13 | 07:03 am
- TheStreet Ratings Top 10 Rating Changes 03.25.13 | 01:03 pm
- Spectrum Pharmaceuticals Inc Stock Downgraded (SPPI) 03.20.13 | 05:03 am
- Healthcare Sector: High Quality Stocks At A Great Value 03.18.13 | 02:03 pm
- 5 Dumbest Things on Wall Street This Week: March 15 03.15.13 | 07:03 am
- The 5 Dumbest Things on Wall Street: March 15
03.15.13 | 05:03 am - Dow Gains for 9th day as IBM Jumps Into Record Territory 03.13.13 | 06:03 pm
- Spectrum Blames Fusilev Sales Warning on Overstuffed Inventory 03.13.13 | 10:03 am
- Stock Futures Turn Higher After Retail Sales Data 03.13.13 | 09:03 am
Press Releases for SPPI
- Abraham, Fruchter & Twersky, LLP Announces That A Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.22.13 | 12:03 pm
- Lifshitz Law Firm Announces Investigation Of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., And Tech Data Corporation - PR Newswire 03.22.13 | 11:03 am
- Hagens Berman Notifies Spectrum Pharmaceuticals Investors Of Pending Class-Action Lawsuit And May 13, 2013, Lead Plaintiff Deadline - Business Wire 03.22.13 | 09:03 am
- Spectrum Pharmaceuticals, Inc. Sued By Shareholders - PR Newswire 03.21.13 | 07:03 pm
- Spectrum Pharmaceuticals Shareholder Alert: Briscoe Law And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors - Business Wire 03.21.13 | 10:03 am
- Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, As Chief Medical Officer - Business Wire 03.18.13 | 07:03 am
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.15.13 | 04:03 pm
- Ryan & Maniskas, LLP Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. - PR Newswire 03.15.13 | 03:03 pm
- Spectrum Pharmaceuticals To Present Corporate Update At The 25th Annual ROTH Conference In Laguna Niguel On March 20th - Business Wire 03.15.13 | 07:03 am
- Spectrum Pharmaceuticals Gains Rights To Pivotal-Stage Captisol-Enabled® Melphalan - Business Wire 03.14.13 | 07:03 am
Partner Headlines for SPPI
- This Drug Market Could Expand 80-Fold by 2020 - NASDAQ 10.17.12 | 01:10 pm
- SPPI a Step Closer to Allos - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- Spectrum Extends Allos Buyout Offer - Analyst Blog - NASDAQ 08.21.12 | 02:08 pm
- Notable Small-Cap Insider Sells Filed On August 16 - Seeking Alpha 08.17.12 | 09:08 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics - Benzinga 07.20.12 | 06:07 pm
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
- Kraft Hits a SELECT LIST and 4 Stocks with New Analyst Insights Now - Wall St. Cheat Sheet 07.02.12 | 01:07 pm
- Spectrum Extends Allos Tender Offer - Analyst Blog - Zacks 06.25.12 | 10:06 am
